{
  "pdfPath": "/home/arkantu/Documentos/Zotero Biblioteca/Neurología/Clinical practice/Clinical Reasoning/Findling et al. - 2008 - Clinical Reasoning Rhabdomyolysis after combined treatment with simvastatin and fluconazole.pdf",
  "fileName": "Findling et al. - 2008 - Clinical Reasoning Rhabdomyolysis after combined treatment with simvastatin and fluconazole.pdf",
  "relativePath": "Neurología/Clinical practice/Clinical Reasoning/Findling et al. - 2008 - Clinical Reasoning Rhabdomyolysis after combined treatment with simvastatin and fluconazole.pdf",
  "text": "RESIDENT\n& FELLOW\nSECTION\n                                  Clinical Reasoning:\nSection Editor                    Rhabdomyolysis after combined treatment\nMitchell S.V. Elkind,\nMD, MS                            with simvastatin and fluconazole\n\nO. Findling, MD                   SECTION 1                                                                 revealed that she had been treated 3 weeks earlier\nN. Meier, MD                      A 65-year-old woman with obesity, hypertension,                           with fluconazole 800 mg daily for 3 weeks, for a Can-\nJ. Sellner, MD                    coronary artery disease, ventricular tachycardia, and                     dida albicans infection of her internal defibrillator.\nK. Nedeltchev, MD                 hypercholesterolemia presented with 2 weeks of pro-                       Simultaneously she had been taking simvastatin 40\nM. Arnold, MD                     gressive, proximal muscle tenderness and weakness.                        mg daily for 5 years.\n                                  She was unable to walk. Neurologic examination re-\nAddress correspondence and                                                                                  Questions for consideration:\n                                  vealed a severe proximal tetraparesis predominantly\nreprint requests to Dr. Marcel\nArnold, Department of             of the legs. Sensation was normal. The patellar reflex                    1. What is the differential diagnosis for symmetric\nNeurology, University Hospital,   was slightly reduced on the right side. The remainder                        proximal weakness?\nInselspital, CH-3010 Bern,\nSwitzerland                       of the examination was normal. Her medical history                        2. What tests would you carry out next?\nmarcel.arnold@insel.ch\n\n\n\n\n                                                                                                                                                       GO TO SECTION 2\n\n\n\n\n                                  From the Department of Neurology (O.F., N.M., K.N., M.A.), Inselspital, Bern University Hospital, and University of Bern, Switzerland; and the\n                                  Department of Neurology (J.S.), Klinikum rechts der Isar, Technische Universität München, Germany.\n                                  Disclosure: The authors report no disclosures.\n\n\n\ne34                               Copyright © 2008 by AAN Enterprises, Inc.\n\fSECTION 2                                                   toms, or ocular symptoms. Furthermore, a disorder\nIn patients with progressive tetraparesis, myelopathy of    of the neuromuscular junction would not explain the\nthe cervical spine must be excluded promptly. This con-     proximal pain.\nsideration is important even in patients without addi-          Myopathy (polymyositis or rhabdomyolysis) is one\ntional signs of myelopathy, such as sensory loss or         of the most likely diagnoses in our patient. Laboratory\nbladder dysfunction. In this patient, MRI scan of the       evaluation showed a creatine kinase (CK) up to 32,000\ncervical spine was normal.                                  U/L (normal ⬍167 U/L). Sedimentation rate was 51\n    An important differential diagnosis is acute motor\n                                                            mm/hour (normal ⬍20) and C-reactive protein was 22\npolyradiculoneuropathy, which is characterized by\n                                                            mg/L (normal ⬍5). Blood chemistry showed increased\nprogressive motor weakness and hyporeflexia. Al-\n                                                            transaminases (aspartate transaminase 1,461 U/L [nor-\nthough neuropathic pain can occur, muscular tender-\n                                                            mal 10 –37], alanine transaminase 671 U/L [normal\nness, as in our patient, is not typical. Furthermore, our\n                                                            5–41]) and lactate dehydrogenase 3,139 U/L (normal\npatient’s tendon reflexes were normal except for a\n                                                            ⬍480). Serum electrophoresis was normal; urine elec-\nslightly reduced right patellar reflex, making radicu-\nlopathy or neuropathy less likely. Motor neuron dis-        trophoresis showed myoglobinuria.\nease, such as amyotrophic lateral sclerosis, is another         Electromyography of the right vastus medialis and ili-\ndifferential diagnosis, but symptoms develop over           opsoas, erector spinae, and left deltoid and tibialis anterior\nmonths or years, and not so rapidly as in our patient.      muscles showed no signs of denervation, but a myopathic\nA disorder of the neuromuscular junction, such as           interference pattern analysis. An MRI scan of the proximal\nmyasthenia gravis, is possible, although there was no       leg muscles revealed edematous swelling and contrast agent\ncharacteristic history of fatigue, fluctuating symp-        enhancement, especially in the adductors (figure).\n\n\n  Figure      MRI of thigh showing muscular atrophy on native T1 imaging with fat suppression (A) and diffuse\n              contrast agent enhancement (B) especially in the adductor muscles\n\n\n\n\n                                                            Neurology 71    October 7, 2008                          e35\n\f          Different types of myopathies such as toxic, metabolic,        biopsy of the left vastus medialis muscle revealed no signs\n      infectious, autoimmune-mediated, and hereditary myopa-             of metabolic or hereditary myopathy. The onset of heredi-\n      thies are to be considered. Blood examination showed no            tary myopathies is often in childhood and symptoms de-\n      evidence of parasitic, bacterial, or viral infection as a reason   velop over months to years.\n      for infectious disease. Furthermore, there were no signs of\n      autoimmune-mediated myopathy (negative antinuclear\n                                                                         Question for consideration:\n      antibody and antineutrophil cytoplasmic antibody, nega-\n      tive antibodies to double stranded-DNA, histones, nucleo-          1. What is the diagnosis and what treatment would\n      some, cardiolipin-, and ribonucleoprotein). In addition,              you recommend?\n\n\n\n                                                                                                            GO TO SECTION 3\n\n\n\n\ne36   Neurology 71    October 7, 2008\n\fSECTION 3                                                   CYP 2A9), which are not oxidized by the cyto-\nThe history of exposure to both simvastatin and flu-        chrome P 450 system, the rate is 0.15/million\nconazole, in combination with the electrodiagnostic,        prescriptions.4\nlaboratory, and MRI findings, led to a diagnosis of             The pathogenesis of statin-induced myopathies is\nstatin-induced rhabdomyolysis.                              not completely understood. Possibly, a disturbance\n    Simvastatin was stopped, therapy with methyl-           of the plasma membrane of muscle cells and influx of\nprednisolone 1,000 mg IV daily was begun (for 3             calcium ions leads to overcontraction and breakdown\ndays, until normal muscle biopsy results returned),         of the contractile apparatus. Ensuing disturbance of\nand bicarbonate infusions were performed.                   protein synthesis and mitochondrial metabolism\n    Muscle strength slowly increased after 1 week,          may cause cell death.3,6,7\nand muscle pain remitted after 2 weeks. All labora-             Management consists of discontinuing the trig-\ntory values normalized within 4 weeks. After 9 weeks        gering agent. Additional measures are bicarbonate in-\nof an inpatient rehabilitation program, she was able        fusion to prevent dissociation of nephrotoxic\nto walk 500 meters without assistance.                      myoglobin, fluid replacement, and promotion of di-\n                                                            uresis.8 The prognosis after stopping the trigger is\nDISCUSSION           Rhabdomyolysis is characterized        good, but in severe cases muscle paresis can persist.\nby widespread muscle pain, tenderness, weakness,                Drugs that are well-tolerated when used sepa-\nand dark urine. Laboratory findings include elevated        rately may induce serious side effects when used in\ntransaminases, myoglobinuria, elevated CK, rapidly          combination. If simvastatin had been temporarily\nrising serum creatinine, and metabolic acidosis. MRI        discontinued during the treatment with fluconazole\nshows muscle edema and contrast enhancement.                this side effect may have been avoided.\nElectromyographic findings often show nonspecific\nsigns of myopathy. Biopsy findings such as multiple\nnecrotic fibers invaded by macrophages can support          REFERENCES\nthe diagnosis. However, there is limited sensitivity,       1. Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis:\nand a negative biopsy cannot exclude the diagnosis.1,2         an evaluation of 475 hospitalized patients. Medicine 2005;\n                                                               84:377–385.\n    Risk factors for statin-induced rhabdomyolysis in-\n                                                            2. Moratalla MB, Braun P, Fornas GM. Importance of MRI\nclude older age, female sex, obesity, renal or liver dys-      in the diagnosis and treatment of rhabdomyolysis. Eur J\nfunction, diabetes, infections, major surgery or               Radiol 2008;65:311–315.\ntrauma, alcoholism, drug interactions, excessive exer-      3. Mukhtar RY, Reckless JP. Statin-induced myositis: a com-\ncise, and exorbitant consumption of grapefruit or              monly encountered or rare side effect? Curr Opin Lipidol\ncranberry juice.3                                              2005;16:640–647.\n                                                            4. Law M, Rudnicka AR. Statin safety: a systematic review.\n    Simvastatin, which our patient had taken for 5\n                                                               Am J Cardiol 2006;97:S52–60.\nyears, is metabolized by the cytochrome P 450 sys-          5. Spina E, Scordo MG, D’Arrigo C. Metabolic drug interac-\ntem, especially by the CYP 3A4 isoenzyme. Inhibi-              tions with new psychotropic agents. Fund Clin Pharmacol\ntors of P450 include fluconazole, as well as                   2003;17:517–538.\nerythromycin, troleandomycin, nefazodone, ritona-           6. Hodel C. Myopathy and rhabdomyolysis with lipid-\nvir, and grapefruit juice.4,5 For lovastatin, simvasta-        lowering drugs. Toxicol Lett 2002;128:159–168.\n                                                            7. Owczarek J, Jasinska M, Orszulak-Michalak D. Drug-\ntin, and atorvastatin, which are metabolized by CYP\n                                                               induced myopathies. An overview of the possible mecha-\n3A4, an incidence of 0.73 cases/million prescriptions\n                                                               nisms. Pharmacol Rep 2005;57:23–34.\nhas been reported. For pravastatin (excreted to a sig-      8. Jain K. Drug-Induced Neurological Disorders. 2nd ed.\nnificant extent unchanged in the urine, CYP3A4                 Göttingen-Seattle-Bern: Hogrefe & Huber; 2001:243–\nplays only a minor role) and fluvastatin (oxidized by          273.\n\n\n\n\n                                                            Neurology 71    October 7, 2008                         e37\n\fClinical Reasoning: Rhabdomyolysis after combined treatment with simvastatin and\n                                    fluconazole\n                       O. Findling, N. Meier, J. Sellner, et al.\n                            Neurology 2008;71;e34-e37\n                     DOI 10.1212/01.wnl.0000327566.57661.09\n\n                       This information is current as of October 6, 2008\n\n Updated Information &                including high resolution figures, can be found at:\n Services                             http://www.neurology.org/content/71/15/e34.full.html\n\n References                           This article cites 7 articles, 0 of which you can access for free at:\n                                      http://www.neurology.org/content/71/15/e34.full.html##ref-list-1\n Subspecialty Collections             This article, along with others on similar topics, appears in the\n                                      following collection(s):\n                                      All Clinical Neurology\n                                      http://www.neurology.org//cgi/collection/all_clinical_neurology\n                                      All Education\n                                      http://www.neurology.org//cgi/collection/all_education\n                                      All Toxicology\n                                      http://www.neurology.org//cgi/collection/all_toxicology\n                                      Muscle disease\n                                      http://www.neurology.org//cgi/collection/muscle_disease\n Permissions & Licensing              Information about reproducing this article in parts (figures,tables) or in\n                                      its entirety can be found online at:\n                                      http://www.neurology.org/misc/about.xhtml#permissions\n Reprints                             Information about ordering reprints can be found online:\n                                      http://www.neurology.org/misc/addir.xhtml#reprintsus\n\n\n\n\nNeurology ® is the official journal of the American Academy of Neurology. Published continuously since\n1951, it is now a weekly with 48 issues per year. Copyright . All rights reserved. Print ISSN: 0028-3878.\nOnline ISSN: 1526-632X.",
  "wordCount": 1408,
  "indexed": "2025-09-25T22:53:51.332Z",
  "method": "direct"
}
